TICI UNICO

by MED-ELAT

Provide hands-free, invisible cochlear implant hearing without external devices or recharging.

DeployStage 4 of 5

CE Mark approved Sep 2026. Clinical trial with 30 patients showed comparable hearing.

Updated 12d agoChecked 11 Oct0 updates this week

Milestones

Next · Rollout begins in European markets
  1. First multi-channel cochlear implant developed1977Complete.
  2. MED-EL company founded1990Complete.
  3. First behind-the-ear processor launched1991Complete.
  4. TICI UNICO pivotal study completedSep 2025Complete.
  5. CE Mark approval received29 Sep 2026Complete.
  6. Rollout begins in European marketsTarget Q4 2026Current milestone.
  7. US FDA submission or approvalTarget 2027Not yet reached.

Most important updates

Upcoming

  1. Q4 2026Rollout begins in European markets (next)
  2. 2027US FDA submission or approval
  3. 2027European market rollout
Primer